Jonathan Weyne

Jonathan Weyne currently serves as the Vice President and Ophthalmology Therapeutic Area Lead at Regeneron Pharmaceuticals, where involvement includes overseeing both Early Clinical Development and strategic initiatives since October 2013. Prior to this role, Jonathan operated as Senior Director and Director of Early Clinical Development at Ridgeback Capital from January 2006 to October 2013, and held the position of Senior Healthcare Analyst. Educational credentials include a Fellowship in Cornea External Disease from Wills Eye Hospital (2001-2002), an MD in Medicine from New York Medical College (1993-1997), and dual Bachelor of Arts degrees in Biology from the University of Pennsylvania (1989-1993).